Nabilone reduces pain and improves sleep and quality of life in diabetic peripheral neuropathic pain
How to Cite
OrthoEvidence. Nabilone reduces pain and improves sleep and quality of life in diabetic peripheral neuropathic pain. ACE Report. 2018;7(10):9. Available from: https://myorthoevidene.com/AceReport/Report/10380
An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic painPain. 2012 Oct;153(10):2073-82. https://dx.doi.org/10.1016/j.pain.2012.06.024
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
26 adults with diabetic neuropathic pain were randomized to receive either oral nabilone (a synthetic cannabinoid) or placebo for 5 weeks. The primary outcome was the average daily pain score, and secondary outcomes included sleep, anxiety, depression, treatment satisfaction, and quality of life. Results demonstrated that nabilone was more effective than placebo for reducing pain, improving sleep...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE